• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫化学粪便隐血试验用于结直肠癌检测的回顾性研究。

A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection.

机构信息

Department of Gastroenterology, National Cancer Center Hospital East, Chiba, Japan.

出版信息

Clin Chim Acta. 2010 Jun 3;411(11-12):802-5. doi: 10.1016/j.cca.2010.02.057. Epub 2010 Feb 23.

DOI:10.1016/j.cca.2010.02.057
PMID:20184867
Abstract

BACKGROUND

Colonoscopic examination is the common pathway for positive screening tests detecting colorectal lesions. We evaluated a specific, quantitative high-throughput automatic immunochemical fecal occult blood test (Auto iFOBT) method for colorectal cancer (CRC) screening and to determine its concordance with physician assessments informed by complete colonoscopy, the gold-standard technique for evaluation of the colonic mucosa.

METHODS

1200 CRC symptomatic patients were recruited for a retrospective investigation. Colorectal neoplasia were localized by colonoscopy and cancer outcomes were enumerated according to severity. In addition, stool samples were collected and analyzed by Auto iFOBT to derive sensitivity, specificity, and positive predictive value. Qualitative colonoscopy and Auto iFOBT results were correlated, as were cancer severities and quantitative hemoglobin concentrations.

RESULTS

Ninety-one patients were found positive for CRC; 50 mucosal, 20 submucosal, and 21 advanced. At standard cutoff, sensitivity was 60%, 90%, and 95%, respectively. Specificity and positive predictive value for all neoplasia and cancers were 89.6% and 86.4%, and 60.9% and 33.7%, respectively. Cancer severities could be approximated roughly according to hemoglobin concentrations.

CONCLUSIONS

Specific qualitative 2-day Auto iFOBT is an accurate tool for the detection of colorectal cancer and therefore provides the basis for a large-scale screening program.

摘要

背景

结肠镜检查是检测结直肠病变的常用筛查检测途径。我们评估了一种特定的、高通量的自动免疫化学粪便潜血检测(Auto iFOBT)方法,用于结直肠癌(CRC)筛查,并确定其与完整结肠镜检查的一致性,完整结肠镜检查是评估结肠黏膜的金标准技术。

方法

1200 名 CRC 症状患者被招募进行回顾性研究。通过结肠镜检查定位结直肠肿瘤,根据严重程度计算癌症结局。此外,收集粪便样本并通过 Auto iFOBT 进行分析,以得出敏感性、特异性和阳性预测值。对定性结肠镜检查和 Auto iFOBT 结果进行了相关性分析,以及癌症严重程度和定量血红蛋白浓度的相关性分析。

结果

91 名患者被发现患有 CRC;50 名黏膜、20 名黏膜下和 21 名晚期。在标准截点下,敏感性分别为 60%、90%和 95%。所有肿瘤和癌症的特异性和阳性预测值分别为 89.6%和 86.4%,60.9%和 33.7%。根据血红蛋白浓度可以大致估算癌症的严重程度。

结论

特定的定性 2 天 Auto iFOBT 是一种用于检测结直肠癌的准确工具,因此为大规模筛查计划提供了基础。

相似文献

1
A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection.免疫化学粪便隐血试验用于结直肠癌检测的回顾性研究。
Clin Chim Acta. 2010 Jun 3;411(11-12):802-5. doi: 10.1016/j.cca.2010.02.057. Epub 2010 Feb 23.
2
A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.一项用于结直肠癌检测的免疫化学粪便潜血试验的多中心前瞻性研究。
J Med Assoc Thai. 2007 Nov;90(11):2291-5.
3
Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.粪便 DNA 检测用于免疫化学粪便隐血试验阳性人群的结直肠癌非侵入性诊断。
Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2647-54. doi: 10.1158/1055-9965.EPI-10-0291.
4
Fecal occult blood testing.粪便潜血试验
Clin Lab Med. 2009 Sep;29(3):523-41. doi: 10.1016/j.cll.2009.06.008.
5
Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.定量免疫化学粪便隐血试验的累积评估,以确定其最佳临床应用。
Cancer. 2010 May 1;116(9):2115-25. doi: 10.1002/cncr.25012.
6
One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.采用粪便潜血联合检测及远端结肠检查进行一次性结直肠癌筛查。
N Engl J Med. 2001 Aug 23;345(8):555-60. doi: 10.1056/NEJMoa010328.
7
A combination of serum markers for the early detection of colorectal cancer.联合检测血清标志物用于结直肠癌的早期检测。
Clin Cancer Res. 2010 Dec 15;16(24):6111-21. doi: 10.1158/1078-0432.CCR-10-0119. Epub 2010 Aug 26.
8
Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.在平均风险的结直肠癌筛查人群中,基于愈创木脂的和定量免疫化学粪便隐血检测的比较。
Am J Gastroenterol. 2010 Sep;105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25.
9
High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy.意大利威尼托地区五种粪便免疫化学检测结直肠癌筛查方案的高敏感性。
Gut. 2011 Jul;60(7):944-9. doi: 10.1136/gut.2010.223982. Epub 2010 Dec 30.
10
Risk for colorectal cancer in elderly persons and possible methodologies for their screening.老年人结直肠癌风险及筛查的可能方法。
Eur J Gastroenterol Hepatol. 2011 May;23(5):431-7. doi: 10.1097/MEG.0b013e328345bc38.

引用本文的文献

1
Refining the Feasibility of Machine-Learning-Based Diagnostic Model Utilizing Gut Microbiota Analysis for Colorectal Cancer Screening.利用肠道微生物群分析优化基于机器学习的诊断模型用于结直肠癌筛查的可行性
Cancer Med. 2025 Jul;14(13):e70935. doi: 10.1002/cam4.70935.
2
Repeat Faecal Immunochemical Testing for Colorectal Cancer Detection in Symptomatic and Screening Patients: A Systematic Review and Meta-Analysis.对有症状患者和筛查患者进行粪便免疫化学检测以筛查结直肠癌:一项系统评价和荟萃分析
Cancers (Basel). 2024 Sep 19;16(18):3199. doi: 10.3390/cancers16183199.
3
Is qFIT a useful tool in prioritising symptomatic patients referred with suspect colorectal cancer in the COVID-19 era?
在 COVID-19 时代,qFIT 是否是一个有用的工具,用于对有疑似结直肠癌症状的患者进行优先排序?
Ulster Med J. 2022 May;91(2):79-84. Epub 2022 Jun 15.
4
Electrochemical biosensors for measurement of colorectal cancer biomarkers.电化学生物传感器用于结直肠癌生物标志物的测量。
Anal Bioanal Chem. 2021 Apr;413(9):2407-2428. doi: 10.1007/s00216-021-03197-8. Epub 2021 Mar 5.
5
Application of Multiplex Bisulfite PCR-Ligase Detection Reaction-Real-Time Quantitative PCR Assay in Interrogating Bioinformatically Identified, Blood-Based Methylation Markers for Colorectal Cancer.多重亚硫酸氢盐 PCR-连接酶检测反应-实时定量 PCR 分析在探索基于血液的结直肠癌生物信息学鉴定甲基化标记物中的应用。
J Mol Diagn. 2020 Jul;22(7):885-900. doi: 10.1016/j.jmoldx.2020.03.009. Epub 2020 May 12.
6
Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis.粪便免疫化学试验检测结直肠癌的阶段特异性敏感性:系统评价和荟萃分析。
Am J Gastroenterol. 2020 Jan;115(1):56-69. doi: 10.14309/ajg.0000000000000465.
7
Diagnostic Accuracy Of Fecal Occult Blood Tests For Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review And Meta-Analysis.粪便潜血试验检测近端与远端结直肠肿瘤的诊断准确性:一项系统评价与Meta分析
Clin Epidemiol. 2019 Oct 25;11:943-954. doi: 10.2147/CLEP.S213677. eCollection 2019.
8
Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.有症状患者中基于症状或粪便免疫化学检测的结直肠癌检测转诊标准:一项诊断试验研究
BMC Gastroenterol. 2018 Oct 25;18(1):155. doi: 10.1186/s12876-018-0887-7.
9
Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal Cancer.用于早期检测结直肠癌的血液DNA甲基化生物标志物
J Proteomics Bioinform. 2018;11(6):120-126. doi: 10.4172/jpb.1000477. Epub 2018 Jun 26.
10
Significant association of PRMT6 hypomethylation with colorectal cancer.PRMT6低甲基化与结直肠癌的显著关联。
J Clin Lab Anal. 2018 Nov;32(9):e22590. doi: 10.1002/jcla.22590. Epub 2018 Jun 21.